BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36805201)

  • 1. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
    Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
    Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
    Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
    Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastrum testudinis extract suppresses osteoclast differentiation via the NF-κB signaling pathway and ameliorates senile osteoporosis.
    Chen H; Shen G; Shang Q; Zhang P; Yu D; Yu X; Zhang Z; Zhao W; Wu Z; Tang F; Liang D; Jiang X; Ren H
    J Ethnopharmacol; 2021 Aug; 276():114195. PubMed ID: 33974944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
    Yang T; Chen W; Gan K; Wang C; Xie X; Su Y; Lian H; Xu J; Zhao J; Liu Q
    J Transl Med; 2023 Nov; 21(1):839. PubMed ID: 37993937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avicularin Alleviates Osteoporosis in Ovariectomized Mice by Inhibiting Osteoclastogenesis through NF-κB Pathway Inhibition.
    Zhuang Q; Chen S; Zhang W; Gu M; Xiao L; Li Y; Yang Y; Feng C; Li H; Geng D; Wang Z
    J Agric Food Chem; 2023 Jan; 71(1):411-420. PubMed ID: 36540936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
    Yuan SG; Hu HL; Wang XJ; Yang JC; Zhou RP; Bai XC; Lai PL
    Orthop Surg; 2022 Jun; 14(6):1203-1216. PubMed ID: 35470579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
    Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine, a
    Luo N; Zhang L; Xiu C; Luo X; Hu S; Ji K; Liu Q; Chen J
    Food Funct; 2024 Feb; 15(4):2154-2169. PubMed ID: 38311970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.
    Wang Y; Li X; Zhou S; Li J; Zhu Y; Wang Q; Zhao F
    Oxid Med Cell Longev; 2022; 2022():7727006. PubMed ID: 36148414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumambrin A prevents OVX-induced osteoporosis
    Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
    FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of Intracellular Alpha-Ketoglutarate Levels Inhibits Osteoclastogenesis by Suppressing the NF-κB Signaling Pathway in a PHD1-Dependent Manner.
    Tian J; Bao X; Yang F; Tang X; Jiang Q; Li Y; Yao K; Yin Y
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.